- Home
- CYAB vs INM Comparison
CYAB vs INM Comparison
Compare CYAB & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$1.33
Company Overview
Basic Information| Metric | CYAB | INM |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 7.1M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CYAB | INM |
|---|---|---|
| Price | $0.16 | $1.33 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 55.9K |
| Earning Date | 11-18-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | $42.03 | N/A |
| Revenue Next Year | $77.74 | $26.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.16 | $0.58 |
| 52 Week High | $3.98 | $2.33 |
Technical Indicators
Market Signals| Indicator | CYAB | INM |
|---|---|---|
| Relative Strength Index (RSI) | 29.73 | 47.52 |
| Support Level | N/A | $1.25 |
| Resistance Level | $0.35 | $1.40 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 4.20 | 25.00 |
Price Performance
Historical Comparison CYAB
INM
About CYAB Cyabra Inc. Common Stock
Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.